除細動器の世界市場（2022年～2028年）

世界の除細動器の市場規模は、予測期間中にCAGRで6.9%の大幅な成長が予測されています。市場の成長の要因として、疾病の増加が挙げられます。

当レポートでは、世界の除細動器市場について調査分析し、市場概要、競合情勢、セグメント分析、地域分析などを提供しています。

目次

第1章 レポートサマリー

第2章 市場概要と考察

• 調査範囲
• アナリストの考察と現在の市場動向

第3章 競合情勢

• 主要企業分析
• 主要戦略分析
• 主要企業に対するCOVID-19の影響

第4章 市場セグメンテーション

• 世界の除細動器市場：タイプ別
  • 植込み型除細動器
  • 体外式除細動器
• 世界の除細動器市場：エンドユーザー別
  • 病院
  • 外来サービス
  • その他

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• その他の地域

第6章 企業プロファイル

• Dynabook Europe GmbHAbbott Laboratories, Inc.
• Bexen Cardio
• Biotronik SE & Co. KG
• Boston Scientific Corp.
• CardiolineSpA
• Cintas Corp.
• Defibtech, LLC
• Fukuda Denshi Co., Ltd.
• General Electric Co.
• HeartSine Technologies LLC
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic PLC
• Metrax GmbH
• Mindray Medical International Co. Ltd.
• Nihon Kohden Corp.
• ProgettiSRL
• Schiller AG
• Stryker Corp.
• ZOLL Medical Corp. (an Asahi Kasei Group Co.)

LIST OF TABLES

• 1. GLOBAL DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE,2021-2028 ($ MILLION)
• 2. GLOBALIMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBALEXTERNAL CARDIOVERTER DEFIBRILLATORSMARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBAL DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 5. GLOBAL DEFIBRILLATORS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL DEFIBRILLATORS IN AMBULATORY SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 7. GLOBAL DEFIBRILLATORS IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION,2021-2028 ($ MILLION)
• 8. GLOBAL DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BYGEOGRAPHY,2021-2028 ($ MILLION)
• 9. NORTH AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 10. NORTH AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE,2021-2028 ($ MILLION)
• 11. NORTH AMERICAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)
• 12. EUROPEAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 13. EUROPEAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE,2021-2028 ($ MILLION)
• 14. EUROPEAN DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)
• 15. ASIA-PACIFIC DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 16. ASIA-PACIFIC DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE,2021-2028 ($ MILLION)
• 17. ASIA-PACIFIC DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)
• 18. REST OF THE WORLD DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 19. REST OF THE WORLD DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY TYPE,2021-2028 ($ MILLION)
• 20. REST OF THE WORLD DEFIBRILLATORS MARKET RESEARCH AND ANALYSIS BY END-USER,2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL DEFIBRILLATORS MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL DEFIBRILLATORS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL DEFIBRILLATORS MARKET, 2022-2028 (%)
• 4. GLOBAL DEFIBRILLATORS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
• 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 6. GLOBAL EXTERNAL CARDIOVERTER DEFIBRILLATORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 7. GLOBAL DEFIBRILLATORS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
• 8. GLOBALDEFIBRILLATORS IN HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 9. GLOBAL DEFIBRILLATORS IN AMBULATORY SERVICES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 10. GLOBAL DEFIBRILLATORS IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 11. US DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 12. CANADA DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 13. UK DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 14. FRANCE DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 15. GERMANY DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 16. ITALY DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 17. SPAIN DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 18. REST OF EUROPE DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 19. INDIA DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 20. CHINA DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 21. JAPAN DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 22. SOUTH KOREA DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 23. REST OF ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)
• 24. REST OF THE WORLD DEFIBRILLATORS MARKET SIZE, 2021-2028 ($ MILLION)

Global Defibrillators Market Size, Share & Trends Analysis by Type (Implantable Cardioverter Defibrillators and External Cardioverter Defibrillators), andby End-User (Hospitals, Ambulatory Services,andOthers) Forecast Period (2022-2028)

The global defibrillators market is anticipated to grow at a significant CAGR of 6.9% during the forecast period. The attributable factor for the growth of the market includes an increase in the number of diseases. Cardiovascular diseases are the leading cause of death in the US, accounting for almost 836,546 mortalities (roughly one out of every three deaths). During the forecast period, the rising frequency of cardiovascular disease in the region is expected to fuel market growth. According to the American Heart Association's research program, cardiovascular illnesses are the leading cause of death in the US, accounting for about 836,546 fatalities. When comparing mortality from all types of cancer and chronic lower respiratory disorders together, deaths from cardiovascular diseases are higher.

The global defibrillators market is segmented based on type and end-users. Based on type, the market is bifurcated into implantable cardioverter defibrillators and external cardioverterdefibrillators. External cardioverter-defibrillators are expected to have a prominent share in the global market owing to technology improvements and initiatives that promote public access to AEDs. In the UK, a measure to improve the availability and accessibility of AEDs (Public Access) is in the works. If the bill passes, installing defibrillators in public locations will become required, increasing the demand for AEDs. In numerous significant areas, such as the US, Canada, Italy, Japan, Australia, and China, favorable legislative policies and activities by public and commercial health groups to encourage public access to defibrillators already exist. Further, increasing implantable procedures adoption of cardiac resynchronization therapy defibrillators across the globe are contributing to the segmental growth of the market. Based on end-user, the market is classified into hospitals, and ambulatory surgical centers & others.

The global defibrillators market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Asia Pacific regional market is expected to cater to considerable growth during the forecast period. Significant rise in the prevalence of CVD, improving healthcare infrastructure and government efforts for the prevention and treatment of non-communicable diseases are some of the major factors boosting the growth of the market in the region. Major economies contributing to the regional growth of the market include China, Japan, and India.

The major companies serving the global defibrillators market include Medtronic PLC, Boston Scientific Corp., Koninklijke Philips N.V., and Abbott Laboratories, Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, new launches, and partnerships. For instance, in June 2019, Cardiac Science Corp. (CSC) signed a definitive agreement to be acquired by ZOLL Medical Corp., an Asahi Kasei Group Co. Through this acquisition, ZOLL aims to expand its defibrillation and monitoring devices product portfolio.

Research Methodology

The market study of the global defibrillators market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Defibrillators Market Research and Analysis by Type.

2. Global Defibrillators Market Research and Analysis by End-User.

The Report Covers

• Comprehensive research methodology of the global defibrillators market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the defibrillators market.
• Insights about market determinants that are stimulating the global defibrillators market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

Category- Medical Devices

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Defibrillators Market
• Recovery Scenario of Global Defibrillators Market
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Key Strategy Analysis
• 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

• 4.1. Global Defibrillators Market byType
  • 4.1.1. Implantable Cardioverter Defibrillators
  • 4.1.2. External Cardioverter Defibrillators
• 4.2. Global Defibrillators Market byEnd-User
  • 4.2.1. Hospitals
  • 4.2.2. Ambulatory Services
  • 4.2.3. Others

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Dynabook Europe GmbHAbbott Laboratories, Inc.
• 6.2. Bexen Cardio
• 6.3. Biotronik SE & Co. KG
• 6.4. Boston Scientific Corp.
• 6.5. CardiolineSpA
• 6.6. Cintas Corp.
• 6.7. Defibtech, LLC
• 6.8. Fukuda Denshi Co., Ltd.
• 6.9. General Electric Co.
• 6.10. HeartSine Technologies LLC
• 6.11. Koninklijke Philips N.V.
• 6.12. LivaNova PLC
• 6.13. Medtronic PLC
• 6.14. Metrax GmbH
• 6.15. Mindray Medical International Co. Ltd.
• 6.16. Nihon Kohden Corp.
• 6.17. ProgettiSRL
• 6.18. Schiller AG
• 6.19. Stryker Corp.
• 6.20. ZOLL Medical Corp. (an Asahi Kasei Group Co.)